Share this post:

S&P Global Market Intelligence covers the Antimicrobial Resistance Benchmark, focusing on the key findings on the performance of large research-based pharmaceutical companies, generic medicine manufacturers and biopharmaceutical companies in the scope of analysis and their efforts to curb antimicrobial resistance.

Read full article